Medication decisions require clinical review. A medication that helps one person may be unsafe for another because of recent substance use, withdrawal timing, pregnancy, liver or kidney disease, seizure history, opioid exposure, psychiatric symptoms, current prescriptions, or overdose risk.
37-15 23rd Ave, Astoria, NY 11105
Approved addiction medicines have specific indications and different starting requirements. A medicine used for opioids is not automatically suitable for alcohol, stimulants, cannabis or gambling. The evaluation matches the diagnosed disorder, treatment goal and health history to the options.
OUD options include buprenorphine, methadone and naltrexone pathways. AUD options include naltrexone, acamprosate and disulfiram. Tobacco treatment has a different group of medicines. Stimulant and cannabis use disorders do not have an FDA-approved medication, although selected off-label treatment may be discussed.
Consider daily versus administered medication, kidney and liver health, opioid exposure, withdrawal, interactions, monitoring and the actual access pathway. Price or visit frequency alone does not decide suitability.
Treatment for opioid use disorder starts with an assessment of opioid use, withdrawal, overdose risk and what you want to change. Medicines can reduce withdrawal or cravings and help protect recovery. Treatment can be appropriate after heroin, fentanyl, nonprescribed pills or problematic prescription opioid use. An evaluation is still useful if you are uncertain about the diagnosis or have returned to use after earlier treatment.
Buprenorphine and methadone activate opioid receptors in controlled ways; naltrexone blocks them and requires an opioid-free starting point. They have different entry requirements and do not offer an identical experience. Naloxone reverses an opioid overdose but is not ongoing OUD treatment. Withdrawal management by itself does not resolve the longer-term risk of relapse and overdose.
The clinician reviews frequency and route of use, loss of control, consequences, tolerance and withdrawal, while distinguishing prescribed use and physical dependence from OUD. Pregnancy, severe symptoms, intoxication, other substance use and health conditions affect the safest setting. Bring any current OUD prescription: transferring care does not necessarily mean starting over, but records and an assessment are needed.
Describe the last opioid use, uncertain pill contents, prior overdoses and current symptoms. Include alcohol, sedatives, stimulants and pain treatment. The clinician assesses whether an outpatient plan is safe or whether urgent, hospital or another level of care is needed. An overdose or unstable condition should not wait for an ordinary clinic appointment.
Compare buprenorphine, methadone and naltrexone against your clinical needs and preferences. Buprenorphine initiation needs a safe plan after recent opioid exposure. Methadone for OUD generally requires an opioid treatment program. Naltrexone requires detoxification and opioid-free assessment. A clinic should help with a suitable referral when the chosen treatment is outside its verified services.
Clarify formulation, pharmacy or injection logistics, return visits, monitoring and whom to call for access problems. Address pain and mental-health treatment at the same time. Discuss counseling, recovery support and barriers such as transportation, housing or work hours without assuming one service can provide every resource.
Have naloxone and an overdose-response plan. Identify what to do after missed medication, renewed use or hospital discharge. A return to use needs reassessment of symptoms, dose coverage and other risks; it should not be hidden because you fear the visit will be wasted.
Bring identification if required for registration, a medication list, pharmacy details, recent treatment records and relevant insurance information. Tell the clinician if you are nearly out of medication or cannot obtain it. Ask how the first prescription or injection is arranged and what follow-up is required. Do not take borrowed treatment or create an opioid-free interval without advice to prepare for the visit.
Call 911 for possible overdose, slow breathing, unresponsiveness, severe chest pain or collapse. Use available naloxone for suspected opioid overdose and follow the product instructions. Alcohol and sedatives can sharply increase risk with opioids or OUD medicines. After a period without opioids, tolerance can be lower, making return to previous use especially dangerous. Pregnancy, dehydration or uncontrolled withdrawal can require urgent assessment.
Ongoing visits review withdrawal, craving patterns, substance use, function and medication effects. Testing, when clinically appropriate, should help interpret the treatment picture; it is not a complete diagnosis by itself. Discuss whether the plan needs more support, a different formulation or another treatment setting. Effective medication may continue for a long time. Stopping requires a plan for relapse prevention and overdose safety.
Ask what the service actually provides: evaluation, ongoing prescribing, injections, counseling or referral. Confirm the specific location, appointment availability, fees and pharmacy or payer requirements. Same-day availability depends on assessment, the intended service and supply. If the requested medicine is unavailable, ask for a safe interim or referral plan rather than waiting without a next step.
Nao Medical Astoria: 37-15 23rd Ave, Astoria, NY 11105. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
Contact the exact service and clinic to confirm the qualified clinician, evaluation modality and available treatment pathway. An electronic prescription, when clinically appropriate, goes to the agreed pharmacy; confirm that pharmacy’s fill and stock status separately. Describe a medication gap promptly and keep the current prescriber involved until responsibility is clear.
The current public clinic record lists 37-15 23rd Ave, Astoria, NY 11105. Confirm the requested service, clinician capability, appointment and any medication delivery at this exact site before traveling. A clinic address does not establish that it administers every treatment.
No. The clinician assesses the substance, diagnosis, current exposure, withdrawal, other medicines, organ function and appropriate level of care before prescribing. Some medicines require opioid-free time, an observed tolerability step, laboratory work or a specialized program. A first visit does not guarantee every medication or an injection that day. Describe urgent withdrawal or a treatment gap promptly.
The assessment can review the exact substance, coexisting conditions and prior treatments. No medication is FDA-approved specifically for cocaine, methamphetamine or cannabis-use disorder. Evidence-based behavioral care and selected specialist off-label options differ from opioid/alcohol/tobacco medication pathways. Confirm that the selected clinician and program provide the needed assessment.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
Opioid-use disorder medication review, follow-up, timing discussion, and insurance support.
Naltrexone, VIVITROL, acamprosate, disulfiram, relapse prevention, and counseling coordination.
Varenicline, bupropion SR, NRT, quit planning, and follow-up.
Cocaine, methamphetamine, and cannabis medication questions can be reviewed without overpromising.
Anxiety, depression, insomnia, trauma, family support, and relapse risk can be coordinated with medication care.
Coverage questions can be reviewed for visits, testing, medications, pharmacy benefits, and follow-up.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local medication support Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local medication support Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View local medication support Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local medication support Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local medication support Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local medication support Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local medication support Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local medication support Get directions